Gil-Gomez, AntonioBrescia, PaolaRescigno, MariaRomero-Gomez, Manuel2023-02-092023-02-092021-03-08Gil-Gómez A, Brescia P, Rescigno M, Romero-Gómez M. Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers. Semin Liver Dis. 2021 May;41(2):191-205.http://hdl.handle.net/10668/17980Nonalcoholic fatty liver disease (NAFLD) is a systemic, dynamic, heterogeneous, and multiaxis entity, the pathogenesis of which is still uncertain. The gut-liver axis is regulated and stabilized by a complex network encompassing a metabolic, immune, and neuroendocrine cross-talk between the gut, the microbiota, and the liver. Changes in the gut-liver axis affect the metabolism of lipids and carbohydrates in the hepatocytes, and they impact the balance of inflammatory mediators and cause metabolic deregulation, promoting NAFLD and its progression to nonalcoholic steatohepatitis. Moreover, the microbiota and its metabolites can play direct and indirect roles in gut barrier function and fibrosis development. In this review, we will highlight findings from the recent literature focusing on the gut-liver axis and its relation to NAFLD. Finally, we will discuss the impact of technical issues, design bias, and other limitations on current knowledge of the gut microbiota in the context of NAFLD.enMicrobiotaMicrobiomeNAFLDNASHGut–Liver axisGastrointestinal MicrobiomeHepatocytesHumansMetagenomeNon-alcoholic Fatty Liver Diseaseresearch article34107545Restricted AccessEnfermedad del hígado graso no alcohólicoHígadoMicrobiotaVoliciónMicrobioma gastrointestinalLípidosConocimientoHepatocitosFibrosis10.1055/s-0041-17237521098-8971http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0041-1723752.pdf